Trade BioNTech BNTX

BioNTech live chart

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

News

Webhose 2025 Dec 08, 12:10

Temasek Holdings Private Ltd Lowers Holdings in BioNTech SE Sponsored ADR $BNTX

BioNTech SE
Webhose 2025 Dec 08, 00:18

Is BioNTech (NasdaqGS:BNTX) Undervalued After Recent Share Price Weakness? A Fresh Look at Its Valuation

BioNTech SE
Webhose 2025 Dec 07, 18:15

BioNTech, OncoC4 presented data from Phase 3 trial for gotistobart | Markets Insider

BioNTech SE
Webhose 2025 Dec 07, 09:36

25,780 Shares in BioNTech SE Sponsored ADR $BNTX Bought by Bollard Group LLC

BioNTech SE
Webhose 2025 Dec 07, 06:28

BioNTech SE Sponsored ADR (NASDAQ:BNTX) Receives Average Rating of "Moderate Buy" from Analysts

BioNTech SE
Webhose 2025 Dec 06, 20:30

BioNTech and OncoC4 Announce Clinically Meaningful Overall Survival Benefit for Selective Treg Modulator Gotistobart in Patients with Previously Treated Squamous Non-Small Cell Lung Cancer

BioNTech SE
Webhose 2025 Dec 05, 09:37

Dodge & Cox Invests $93.42 Million in BioNTech SE Sponsored ADR $BNTX

BioNTech SE
Webhose 2025 Dec 04, 21:22

BioNTech's (BNTX) Buy Rating Reiterated at Jefferies Financial Group

BioNTech SE
Webhose 2025 Dec 04, 05:00

Other news to note for Dec. 4, 2025 | BioWorld

BioNTech SE
Webhose 2025 Dec 03, 20:23

Promising Biotech Stocks To Consider - December 3rd - Markets Daily

BioNTech SE
Webhose 2025 Dec 03, 01:22

The Bull Case For BioNTech (BNTX) Could Change Following Higher Guidance And Oncology Progress - Learn Why

BioNTech SE
Webhose 2025 Dec 01, 23:22

Vaccine stocks slide as FDA official links COVID vaccines and heart conditions in young men | Morningstar

BioNTech SE
Webhose 2025 Dec 01, 17:35

Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men | Morningstar

BioNTech SE
Webhose 2025 Dec 01, 17:09

Vaccine makers fall on FDA memo, Bally's wins bid for NYC casino

BioNTech SE
Webhose 2025 Dec 01, 01:03

BioNTech (BNTX): Assessing Valuation Following Recent Momentum Shift

BioNTech SE
Webhose 2025 Dec 01, 00:16

BioNTech (BNTX) Is Up 7.9% After Raising 2025 Revenue Guidance on Bristol-Myers Collaboration

BioNTech SE
Webhose 2025 Nov 30, 22:16

Evaluating BioNTech (BNTX): Is the Stock Undervalued After Its Recent Uptick?

BioNTech SE
Webhose 2025 Nov 29, 08:36

Virtus Investment Advisers LLC Purchases 1,260 Shares of BioNTech SE Sponsored ADR $BNTX - Stock Observer

BioNTech SE
Webhose 2025 Nov 28, 12:20

Groupama Asset Managment Buys 26,681 Shares of BioNTech SE Sponsored ADR $BNTX - Markets Daily

BioNTech SE
Webhose 2025 Nov 27, 10:52

Legal & General Group Plc Raises Holdings in BioNTech SE Sponsored ADR $BNTX - Markets Daily

BioNTech SE
Webhose 2025 Nov 27, 05:52

Legal & General Group Plc Boosts Stock Position in BioNTech SE Sponsored ADR $BNTX - Stock Observer

BioNTech SE
Webhose 2025 Nov 26, 11:23

Franklin Resources Inc. Acquires 326,556 Shares of BioNTech SE Sponsored ADR $BNTX

BioNTech SE
Webhose 2025 Nov 26, 02:29

BioNTech's (BNTX) "Buy" Rating Reaffirmed at Berenberg Bank - Daily Political

BioNTech SE
Webhose 2025 Nov 26, 01:46

Edmond DE Rothschild Holding S.A. Raises Stock Position in BioNTech SE Sponsored ADR $BNTX - Daily Political

BioNTech SE
Webhose 2025 Nov 26, 00:05

CureVac Announces Voting Results of Extraordinary General Meeting

BioNTech SE
Webhose 2025 Nov 25, 14:30

Berenberg Bank Reaffirms Buy Rating for BioNTech (NASDAQ:BNTX) - Markets Daily

BioNTech SE
Webhose 2025 Nov 22, 08:34

Bank Julius Baer & Co. Ltd Zurich Lowers Stock Holdings in BioNTech SE Sponsored ADR $BNTX

BioNTech SE
Webhose 2025 Nov 21, 10:24

BioNTech SE Sponsored ADR $BNTX Shares Sold by ProShare Advisors LLC - Markets Daily

BioNTech SE
Webhose 2025 Nov 21, 05:24

ProShare Advisors LLC Sells 758 Shares of BioNTech SE Sponsored ADR $BNTX - Stock Observer

BioNTech SE
Webhose 2025 Nov 20, 02:42

Pfizer Is Giving Up on BioNTech. Should You Ditch BNTX Stock Now Too?

BioNTech SE
Webhose 2025 Nov 19, 07:52

Primecap Management Co. CA Reduces Holdings in BioNTech SE Sponsored ADR $BNTX - Stock Observer

BioNTech SE
Webhose 2025 Nov 18, 14:30

BioNTech's (BNTX) "Buy" Rating Reiterated at Berenberg Bank

BioNTech SE
Webhose 2025 Nov 15, 15:20

BioNTech (NASDAQ:BNTX) Shares Gap Down - Should You Sell? - Stock Observer

BioNTech SE
Webhose 2025 Nov 15, 11:56

Mitsubishi UFJ Trust & Banking Corp Sells 17,597 Shares of BioNTech SE Sponsored ADR $BNTX - Markets Daily

BioNTech SE
Webhose 2025 Nov 15, 09:34

A Look at BioNTech (NasdaqGS:BNTX) Valuation Following Pfizer's Complete Stake Sale - Simply Wall St News

BioNTech SE
Webhose 2025 Nov 15, 08:20

Allianz SE Buys 5,080 Shares of BioNTech SE Sponsored ADR $BNTX

BioNTech SE
Webhose 2025 Nov 15, 02:10

A Look at BioNTech (NasdaqGS:BNTX) Valuation Following Pfizer's Share Sale Announcement

BioNTech SE
Webhose 2025 Nov 14, 09:55

Candriam S.C.A. Sells 84,219 Shares of BioNTech SE Sponsored ADR $BNTX

BioNTech SE
Webhose 2025 Nov 14, 06:10

COVID-19 Vaccine: Pfizer Reduces Stake in BioNTech, Marks a Strategic Shift Post-COVID Vaccine Success, ETPharma

BioNTech SE
Webhose 2025 Nov 14, 02:46

Fox Run Management L.L.C. Purchases New Holdings in BioNTech SE Sponsored ADR $BNTX - Daily Political

BioNTech SE
Webhose 2025 Nov 13, 15:53

BioNTech (NASDAQ:BNTX) Shares Gap Down - What's Next? - Markets Daily

BioNTech SE
Webhose 2025 Nov 13, 14:32

Jefferies Financial Group Reaffirms "Buy" Rating for BioNTech (NASDAQ:BNTX)

BioNTech SE
Webhose 2025 Nov 13, 12:38

Quinn Opportunity Partners LLC Trims Position in BioNTech SE Sponsored ADR $BNTX

BioNTech SE
Webhose 2025 Nov 13, 09:50

Pfizer looks to sell stake in pandemic vaccine partner BioNTech - The Business Times

BioNTech SE
Webhose 2025 Nov 13, 04:56

Candriam S.C.A. Has $62.47 Million Stake in BioNTech SE Sponsored ADR $BNTX - Stock Observer

BioNTech SE
Webhose 2025 Nov 11, 21:19

What BioNTech (BNTX)'s Raised 2025 Revenue Guidance Means for Shareholders - Simply Wall St News

BioNTech SE
Webhose 2025 Nov 11, 03:44

BioNTech (NASDAQ:BNTX) Price Target Raised to $140.00 at HC Wainwright - Daily Political

BioNTech SE
Webhose 2025 Nov 10, 13:36

HC Wainwright Issues Positive Forecast for BioNTech (NASDAQ:BNTX) Stock Price - Markets Daily

BioNTech SE

BioNTech News

Frances Wang 2025 Dec 09, 16:00

Technology stock to watch in 2026: What is the new NVDA stock price target?

Frances Wang 2025 Dec 09, 16:00

BMNR stock up 9% today: what’s going on with BitMine Immersion Technologies?

Ghko B 2025 Dec 09, 16:00

Undervalued stocks to buy now: AMD stock, Palantir (PLTR) stock, RBLX stock

Frances Wang 2025 Dec 09, 16:00

Solana (SOL) price analysis: What will SOL/USD be worth in 2026?

Ghko B 2025 Dec 08, 16:00

Why is CRWV stock dropping: will CoreWeave stock double in 2026?

Frances Wang 2025 Dec 08, 16:00

Gold Price trades around $4,200: Will XAU/USD continue its struggles?

Frances Wang 2025 Dec 08, 16:00

NASDAQ: CRWV slid 2.3% today: what’s happening with CoreWeave Inc?

Ghko B 2025 Dec 08, 16:00

Commodity investing: types of commodities, can commodities rally in 2026?

Ghko B 2025 Dec 07, 16:00

EV Stocks Yearly Recap: Rivian (RIVN) Stock, NASDAQ: TSLA, NIO Stock

Frances Wang 2025 Dec 07, 16:00

Quantum Stocks to Watch: IONQ Stock, QBTS Stock, D-Wave Stock

Latest news

Show more
Noah Lee 2025 Dec 06, 17:50

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

Noah Lee 2025 Dec 06, 17:00

Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Liam James 2025 Dec 06, 12:40

Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Ava Grace 2025 Dec 06, 11:50

Market Movers: Fed Rate Decision & Key Economic Data in Focus Next Week

Noah Lee 2025 Dec 06, 10:50

Central Bank Rate Decisions & Market Volatility Outlook: What to Expect

Emma Rose 2025 Dec 06, 09:40

Clear Street Prepares for IPO Amid Crypto Treasury Model Concerns

Ava Grace 2025 Dec 06, 09:30

Crypto Market Analysis and Regulatory Updates: December 6, 2024

Sophia Claire 2025 Dec 06, 08:00

Bitcoin Treasury Firms Face 'Darwinian Phase' Amid Market Shift

Info

Spread

1.1854

Spread (%)

1.2438 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Wednesday

14:31 - 20:59

Monday

14:31-20:59

Tuesday

14:31-20:59

Thursday

14:31-20:59

Friday

14:31-20:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

23047655424

Shares Outstanding

240455450

Earnings Date (Next)

0000-00-00

Div Yield

2022-06-17

Ex-Dividend Date

2022-06-02

Forward annual dividend rate

0

Forward annual dividend yield

0

EPS

-2.78

Learn more about this instrument

BioNTech BioNTech SE
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany. The company develops BNT111, which is in Phase 2 clinical trial for advance melanoma; BNT113, which is in Phase 2 clinical trial to treat head and neck squamous cell carcinoma; BNT116, which is in Phase I clinical trial for non-small cell lung cancer; BNT142, which is in phase 1/2 clinical trial for multiple solid tumors; BNT151, which is in phase 1/2 clinical trial for solid tumors; BNT152+BNT153, which is in phase 1 clinical trial for solid tumors; and BNT122/RO7198457, which is in Phase 2 clinical trial to treat adjuvant high-risk muscle-invasive urothelial carcinoma, colorectal cancer, pancreatic ductal adenocarcinoma, advance melanoma, as well as in phase 1a/1b clinical trial for advanced/metastatic solid tumors. It also develops BNT211, which is in phase 1 clinical trial to treat CLDN6+ solid tumors; BNT221, phase 1 clinical trial for the treatment of cancer; BNT311/GEN1046 (acasunlimab), which is in phase 3 clinical trial for solid tumors; BNT312/GEN1042, which is in phase 1/2 and 1 clinical trial to treat solid tumors; BNT314/GEN1059, which is in Phase 1/2 clinical trial for advanced or metastatic solid tumors; BNT315/GEN1055, which is in phase 1/2 clinical trial for advanced solid tumors; BNT317, which is in phase 1 clinical trial for advanced solid tumors; BNT327, which is in phase 1/2, 2, and 3 clinical trial to treat small cell lung cancer, advanced/metastatic tnbc, neuroendocrine neoplasm, malignant mesothelioma, EGFR-mutant non-squamous, hepatocellular carcinoma, and advanced solid tumors; and BNT316/ONC-392, which is in phase 1/2, 2, and 3 clinical trial to treat metastatic, non-small cell lung cancer, platinum-resistant ovarian cancer, metastatic castration resistant prostate cancer, and advanced or metastatic solid tumor. BioNTech SE was incorporated in 2008 and is headquartered in Mainz, Germany.

Related Instruments

Asset
Sell
Buy
Change (%)
View all instruments

Latest Education Articles

Show more
Ghko B 2025 Dec 08, 16:00

Commodity CFD trading: Types of commodities, how to trade commodities CFDs?

Ghko B 2025 Dec 07, 16:00

Crypto CFD trading: What are crypto CFDs, how to trade crypto with CFDs?

Ghko B 2025 Dec 04, 16:00

How to trade gold: Trading tips on gold CFDs, Short-term trades in XAU/USD

Trustpilot